Pregnancy registries are collecting real-world data on medication safety during pregnancy, helping doctors and patients make informed choices. Here's what we're learning-and where the gaps still remain.
Keep Reading
Sulfonamides and other medications can trigger kernicterus in newborns by displacing bilirubin from albumin, leading to brain damage. Learn the risks, warning signs, and how to prevent this entirely avoidable condition.
Keep Reading
Hydroxyzine is commonly prescribed for anxiety and itching, but it carries a serious risk of QT prolongation and Torsade de Pointes. Learn who's at risk, what doses are safe, and how to avoid life-threatening heart complications.
Keep Reading
Tracking vitamin K with a food diary is essential for warfarin patients to maintain stable INR levels and avoid dangerous bleeding or clotting risks. Consistency in diet beats restriction.
Keep Reading
Learn how Medicare Extra Help cuts generic drug costs to $4.90 per prescription. Discover eligibility rules, application steps, and common pitfalls to avoid. Save up to $6,200 annually with this federal program.
Keep Reading
Every state has different rules for when pharmacists can swap brand-name drugs for generics-or biosimilars. This guide breaks down the 50-state landscape, from mandatory substitution to patient consent and liability risks.
Keep Reading
Illegible handwriting on prescriptions causes thousands of preventable deaths each year. Electronic prescribing has slashed these errors by over 90%, making it the most effective patient safety solution today.
Keep Reading
Learn how hospitals and clinics prevent deadly medication errors through proven safety practices, technology, and human protocols. Discover what works, what doesn't, and how patients can protect themselves.
Keep Reading
Track your body's response when switching to generic medications with a simple medication journal. Learn what to record, why it matters, and how to use it to protect your health.
Keep Reading
Vaccine generics don't exist like drug generics-complex biology, high costs, and concentrated production create global access gaps. Who makes vaccines, who controls supply, and why equity remains out of reach.
Keep Reading